References
- Lebzen G, Knauss K. Über xanthoma multiplex planum, tuberosum, mollusciforme. Arch Pathol Anat Physiol. 1889; 116: 85
- Heiss G, Tyroler H A. Are apolipoproteins useful for evaluating ischemic heart disease? A brief overview of the literature. Proceedings of the Workshop on Apolipoprotein Quantification, K Lippel. 7–24, NIH 1983 Publication No. 83–1266
- Report of the National Cholesterol Education Program Expert Panel on Detection. Evaluation, and Treatment of High Blood Cholesterol in Adults. Arch Intern Med 1988; 148: 36–69
- Lipid Research Clinics Program. The lipid Research Clinics Coronary Primary Prevention trial Results: I. Reduction in incidence of coronary heart disease. J Am Med Assoc 1984; 251: 351–364
- Frick M H, Elo O, Haapa K, Heinonen O P, Heinsalmi P, Helo P, Huttunen J K, Kaitaniemi P, Koskinen P, Manninen V, Maenpaa H, Malkonen M, Manttari M, Norola S, Pas-Ternack A, Pikkarainen J, Romo M, Sjöblom T, Nikkila E A. Helsinki Heart Study: Primary-Prevention Trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of Treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med 1987; 317: 1237–1245
- Blankenhom D H, Nessim S A, Johnson R L, Sanmarco M E, Azen S P, Cashin-Hemphill L. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA 1987; 257: 3233–3240
- Leaf A. Management of hypercholesterolemia: are preventive interventions advisable?. N Engl J Med 1989; 321: 680–684
- Stein E A, Kirkeeide R L, Gould L, Nishikawa Lamkin G. The repetitive plasma exchange/drug trial in familial hypercholesterolemia: very early results from two-year coronary angiograms. Pathology of the Human Atherosclerotic Plaque, S Glagov, W P Newman, S A Schaffcr. Springer-Verlag. 1989; 571–585, 1990
- Goldstein J L, Brown M S. Familial hypercholesterolemia. The Metabolic Basis of Inherited Disease Isixth ed., C R Scriver, A L Beaudet, W S Sly, D Valle, 1215–1250
- Brensike J F, Levy Ri, Kelsey S F, Passamani E R, Richardson J M, Loh I K, Stone N J, Aldrich R F, Battaglini J W, Mori-Arty D J, Fisher M R, Friedman L, Friedewald W, Detre K M, Epstein S E. Effects of therapy with cholestyramine on progression of coronary arteriosclerosis; results of the NHLBI Type II Coronary Intervention Study. Circulation. 1984; 69: 313–324
- Brown B G, Lin J T, Schaefer S M, Kaplan C A, Dodge H T, Albers J J. Niacin or lovastatin, combined with colestipol, regress coronary atherosclerosis and prevent clinical events in men with elevated apolipoprotein B. Circulation (supp.) 1989; 80: 266
- Stein E A, Steiner P M. Triglyceride measurement and its relationship to heart disease. Clin in Lab Med 1989; 9: 169–185
- Gordon D J, Rifkind B M. High-density lipoprotein - the clinical implications of recent studies. N Engl J Med 1989; 321: 1311–1316
- Steinberg D, Parthasarathy S, Carew T E, Khoo J C, Witztum J L. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989; 320: 915–924